These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 9002754

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Treatment of advanced neuroblastoma in children over 1 year of age: the critical role of ¹³¹I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen.
    Mastrangelo S, Rufini V, Ruggiero A, Di Giannatale A, Riccardi R.
    Pediatr Blood Cancer; 2011 Jul 01; 56(7):1032-40. PubMed ID: 21344615
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma.
    Hutchinson RJ, Sisson JC, Miser JS, Zasadny KR, Normolle DP, Shulkin BL, Francis IR, Wieland DM, Shapiro B.
    J Nucl Biol Med (1991); 1991 Jul 01; 35(4):237-40. PubMed ID: 1823826
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Metaiodobenzylguanidine (mIBG) in treatment of 47 patients with neuroblastoma: results of the German Neuroblastoma Trial.
    Klingebiel T, Berthold F, Treuner J, Schwabe D, Fischer M, Feine U, Maul FD, Waters W, Wehinger H, Niethammer D.
    Med Pediatr Oncol; 1991 Jul 01; 19(2):84-8. PubMed ID: 2011100
    [Abstract] [Full Text] [Related]

  • 28. [131I]metaiodobenzylguanidine in neuroblastoma patients at diagnosis.
    Mastrangelo R, Lasorella A, Troncone L, Rufini V, Iavarone A, Riccardi R.
    J Nucl Biol Med (1991); 1991 Jul 01; 35(4):252-4. PubMed ID: 1823829
    [Abstract] [Full Text] [Related]

  • 29. [Initial experiences in the treatment of children with metastatic and recurrent neuroblastoma using meta-iodobenzylguanidine].
    Klingebiel T, Feine U, Niethammer D, Müller-Schauenburg W, Schwabe D, Maul FD, Gerein V, Fischer M, Gahr M, Kraz K.
    Klin Padiatr; 1986 Jul 01; 198(3):230-6. PubMed ID: 3723987
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors.
    Shapiro B, Sisson JC, Shulkin BL, Gross MD, Zempel S.
    Q J Nucl Med; 1995 Dec 01; 39(4 Suppl 1):55-7. PubMed ID: 9002750
    [Abstract] [Full Text] [Related]

  • 32. Treatment of neuroblastoma with [125I]metaiodobenzylguanidine.
    Sisson JC, Shapiro B, Hutchinson RJ, Zasadny KR, Mallette S, Mudgett EE, Wieland DM.
    J Nucl Biol Med (1991); 1991 Dec 01; 35(4):255-9. PubMed ID: 1823830
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Therapeutic use of [131I]metaiodobenzylguanidine in neuroblastoma: a phase II study in 26 patients. "Société Française d'Oncologie Pédiatrique" and Nuclear Medicine Co-investigators.
    Lumbroso J, Hartmann O, Schlumberger M.
    J Nucl Biol Med (1991); 1991 Dec 01; 35(4):220-3. PubMed ID: 1823822
    [Abstract] [Full Text] [Related]

  • 35. Second malignancies in children with neuroblastoma after combined treatment with 131I-metaiodobenzylguanidine.
    Garaventa A, Gambini C, Villavecchia G, Di Cataldo A, Bertolazzi L, Pizzitola MR, De Bernardi B, Haupt R.
    Cancer; 2003 Mar 01; 97(5):1332-8. PubMed ID: 12599242
    [Abstract] [Full Text] [Related]

  • 36. [131I]-metaiodobenzylguanidine in the treatment of metastatic neuroblastoma. Clinical, pharmacological and dosimetric aspects.
    Klingebiel T, Treuner J, Ehninger G, Keller KD, Dopfer R, Feine U, Niethammer D.
    Cancer Chemother Pharmacol; 1989 Mar 01; 25(2):143-8. PubMed ID: 2598401
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [131I]metaiodobenzylguanidine and high-dose chemotherapy with bone marrow rescue in advanced neuroblastoma.
    Corbett R, Pinkerton R, Tait D, Meller S.
    J Nucl Biol Med (1991); 1991 Mar 01; 35(4):228-31. PubMed ID: 1823824
    [Abstract] [Full Text] [Related]

  • 39. Tumor response and toxicity with multiple infusions of high dose 131I-MIBG for refractory neuroblastoma.
    Howard JP, Maris JM, Kersun LS, Huberty JP, Cheng SC, Hawkins RA, Matthay KK.
    Pediatr Blood Cancer; 2005 Mar 01; 44(3):232-9. PubMed ID: 15490487
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.